We simplify complex diabetes data and generate clear, actionable insights that empower clinicians, healthcare professionals, and people living with diabetes to make better-informed decisions. Our mission promotes a targeted patient focus, improves treatment strategies, and fosters a deeper understanding of individuals living with diabetes. We strive to make this new approach the global standard in diabetes care and to support the worldwide diabetes community.
We aim to revolutionize diabetes and pre-diabetes management worldwide, using state-of-the-art technology, leveraging AI/Machine Learning alongside Continuous Glucose Monitoring (CGM) to improve accessibility, effectiveness, and outcomes for patients globally.
The company was founded in 2019 in Stockholm and was then accepted into the Karolinska Institute DRIVE incubator program. Among the co-founders are the Professor of Medicine and Senior Consultant in diabetes, Per-Ola Carlsson (MD PhD) and the Associate Professor of Medicine and Senior Consultant, Daniel Espes (MD PhD), from Uppsala University. Per-Ola Carlsson is the Chief Medical Officer (CMO) and Daniel Espes is the Chief Scientific Officer (CSO) of OneTwo Analytics. Today, OneTwo Analytics consists of a versatile team with expertise in medical technology, clinical development, regulations, artificial intelligence, machine learning, design and healthcare management.
